Telix Pharmaceuticals Limited (TLX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
10.19
-0.09 (-0.88%)
At close: Oct 06, 2025, 10:07 AM

Telix Pharmaceuticals Cash Flow Statement

Financials in AUD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
n/a 5.21M -104.08M -80.51M
Depreciation & Amortization
n/a 6.92M 5.38M 5.17M
Stock-Based Compensation
n/a 8.79M 8.11M 1.32M
Other Working Capital
-64.27M -20.52M -6.5M -101K
Other Non-Cash Items
107.3M 60.5M 41M 31.52M
Deferred Income Tax
n/a n/a -13.38M -14.2M
Change in Working Capital
-64.27M -57.53M -1.01M -2.63M
Operating Cash Flow
43.03M 23.88M -63.97M -59.33M
Capital Expenditures
-34.03M -10.79M -13.86M -1.34M
Cash Acquisitions
-34.69M -1.48M -973K n/a
Purchase of Investments
-51.99M -13.15M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-34.17M -1.17M -2.16M -1.39M
Investing Cash Flow
-135.17M -25.49M -17M -2.73M
Debt Repayment
652.81M 5.76M 3M -340K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-14.88M -2.22M -1.26M -596K
Financial Cash Flow
638.92M 10.19M 174.96M 2.85M
Net Cash Flow
587.11M 6.91M 94.29M -55.91M
Free Cash Flow
9M 13.09M -77.83M -60.67M